GIS
CVS icon

Graphene Investments SAS’s CVS Health CVS Stock Holding History

Graphene Investments SAS’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,100
Closed -$3.36M – 45
2024
Q1 		$3.36M Hold
42,100
– – 2.02% 24
2023
Q4 		$3.32M Hold
42,100
– – 2.16% 7
2023
Q3 		$2.94M Hold
42,100
– – 2.06% 19
2023
Q2 		$2.91M Hold
42,100
– – 1.92% 32
2023
Q1 		$3.13M Buy
42,100
+11,700
+38% +$981K 2.09% 15
2022
Q4 		$2.83M Buy
+30,400
New +$2.93M 1.92% 31

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Graphene Investments SAS's CVS Position: Q2 2024 in Review

Graphene Investments SAS sold out of CVS Health (CVS) in Q2 2024, closing a stake of 42,100 shares — an estimated $3.36M sold.

Graphene Investments SAS first reported a position in CVS in Q4 2022 and held it in 6 quarters. The position peaked at $3.36M in Q1 2024. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Graphene Investments SAS reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Graphene Investments SAS sold 42,100 CVS Health shares in Q2 2024, an estimated $3.36M.
  • Graphene Investments SAS first reported a position in CVS Health in Q4 2022 and held it in 6 quarters.
  • Graphene Investments SAS's CVS Health position peaked at $3.36M in Q1 2024.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Graphene Investments SAS's 13F filing for Q2 2024, filed 19 Jul 2024.